Treatment adherence scale for patients with diabetes and arterial hypertension
Keywords:
compliance and adherence to treatment, surveys and questionnaires, reproducibility of results, diabetes mellitus, hypertension.Abstract
Introduction: Adherence to treatment is fundamental to the success of therapies in patients with chronic diseases. Despite this, people diagnosed with diabetes and hypertension may encounter barriers to adherence to medical recommendations.
Objective: To construct and determine the evidence of validity and reliability of a treatment adherence scale, based on the information, motivation and skills theory, aimed at patients with diabetes and hypertension.
Methods: The research was carried out in a sample of 444 patients between 40 and 64 years of age, with a diagnosis of diabetes and arterial hypertension. Evidence of content validity was analyzed by experts; finally, the internal structure was explored by exploratory factor analysis and reliability by ordinal alpha.
Results: The instrument presented evidence of content validity, Aiken V=1 (0.83-1). Factor analysis identified 6 factors, consistent with the theory: (F1) perceived information, (F2) family support strategy, (F3) motivation for physical exercise and diet, (F4) self-regulation strategy for treatment, (F5) strategy for health care, and (F6) motivation for pharmacological treatment. The reliability of the dimensions was higher than 0.70.
Conclusion: The treatment adherence scale in patients with diabetes and arterial hypertension shows evidence of adequate validity and reliability.
Downloads
Download data is not yet available.
References
1. Organización Mundial de la Salud. Enfermedades no transmisibles. Ginebra: OMS. 2018 [acceso: 16/06/2019]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/noncommunicable-diseases
2. Ministerio de Salud. En el Perú, 40 de cada 100 personas mayores de 15 años sufren de obesidad. Diabetes o hipertensión. Lima: MINSA. 2021 [acceso: 26/02/2023]. Disponible en: https://www.gob.pe/institucion/minsa/noticias/508408-en-el-peru-40-de-cada-100-personas-mayores-de-15-anos-sufren-de-obesidad-diabetes-o-hipertension-arterial
3. Fernandez-Lazaro C, García-González J, Adams D, Fernandez-Lazaro D, Mielgo-Ayuso J, Caballero-Garcia A, et al. Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study. BMC Fam. Pract. 2019; 20(132):1-12. DOI: 10.1186/s12875-019-1019-3
4. Organización Mundial de la Salud. Es hora de actuar: informe de la Comisión Independiente de Alto Nivel de la OMS sobre Enfermedades No Transmisibles. Ginebra: OMS. 2018 [acceso: 16/06/2019]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/272712/9789243514161-spa.pdf?ua=1
5. Ortega J, Sánchez D, Rodríguez O, Ortega J. Adherencia terapéutica: un problema de atención médica. Acta Méd. Grupo Ángeles. 2018 [acceso: 08/12/2022]; 16(3):226-32. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1870-72032018000300226&lng=es
6. Vilcamango-Ugaldez E, Gil-Merino S, Valladares-Garrido M. Factores asociados a la adherencia terapéutica en diabéticos atendidos en dos hospitales peruanos. Rev Cuba de Medicina Mil. 2021 [acceso: 05/12/2022]; 50(2):e02101201. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1201
7. Uchmanowicz B, Chudiak A, Uchmanowicz I, Rosinczuk J, Froelicher E. Factors influencing adherence to treatment in older adults with hypertension. Clin Inter Aging. 2018 [acceso: 07/12/2018]; 13:2425-41. Disponible en: https://www.tandfonline.com/doi/full/10.2147/CIA.S182881
8. Nelson LA, Wallston KA, Kripalani S, LeStourgeon LM, Williamson SE, Mayberry LS. Assessing barriers to diabetes medication adherence using the Information-Motivation-Behavioral skills model. Diabetes Res Clin Pract. 2018; 142:374-84. DOI: 10.1016/j.diabres.2018.05.046
9. Padilla V, Morales J. Adherencia al tratamiento en enfermedades crónicas en adultos mayores. Dom. Cien. 2020 [acceso: 20/02/2022]; 6(4):68-80. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8385958
10. Rodríguez-Reyes J, Fonseca-González K, Salazar-Rodríguez J, Marrero-Martínez D. Adherencia terapéutica en hipertensos con incremento matutino de la presión arterial. Rev Cub de Med. 2020 [acceso: 06/12/2022]; 59(3):e1368. Disponible en: https://revmedicina.sld.cu/index.php/med/article/view/1368
11. Al-Sahouri A, Merrell J, Snelgrove S. Barriers to good glycemic control levels and adherence to diabetes management plan in adults with Type-2 diabetes in Jordan: a literature review. Patient Prefer Adherence. 2019; 13:675-93. DOI: 10.2147%2FPPA.S198828
12. Unni E, Bae S. Exploring a New Theoretical Model to Explain the Behavior of Medication Adherence. Pharmacy. 2022; 10(2):43. DOI: 10.3390/pharmacy10020043
13. Zahmatkeshan N, Rakhshan M, Zarshenas L, Kojuri J, Khademian Z. The Effect of Applying the Information-Motivation-Behavioral Skills Model on Treatment Adherence in Patients with Cardiovascular Disease: A Quasi-Experimental Study. Int J Community Based Nurs Midwifery. 2021; 9(3):225-37. DOI: 10.30476%2Fijcbnm.2021.88987.1563
14. Lee M, Park Y. The effectiveness of the information-motivation-behavioral skills model-based intervention on preventive behaviors against respiratory infection among community-dwelling older adults. Patient Educ Couns. 2021;104(8):2028-36. DOI: 10.1016/j.pec.2021.01.016
15. Luo Y, Yao L, Zhou L, Yuan F, Zhong X. Factors influencing health behaviours during the coronavirus disease 2019 outbreak in China: an extended information-motivation-behaviour skills model. Public Health. 2020; 185:298-305. DOI: 10.1016/j.puhe.2020.06.057
16. Bakir E, Çavusoglu H, Mengen E. Effects of the Information-Motivation-Behavioral Skills Model on Metabolic Control of Adolescents with Type 1 Diabetes in Turkey: Randomized Controlled Study. J. Pediatr. Nurs. 2021;58: e19-e27. DOI: 10.1016/j.pedn.2020.11.019
17. Fisher J, Fisher W. Changing AIDS-risk behavior. Psychol Bull. 1992;111(3):455-74. DOI: 10.1037/0033-2909.111.3.455
18. Dubov A, Altice F, Fraenkel L. An information-motivation-behavioral skills model of PrEP uptake. AIDS Behav. 2018;22(11):3603-16. DOI: 10.1007/s10461-018-2095-4
19. Furtado de Souza T, Fátima Colet C, Heineck I. Knowledge and information levels and adherence to oral anticoagulant therapy with warfarin in patients attending primary health care services. J Vasc Bras. 2018;17(2):109-116. DOI: 10.1590/1677-5449.012017
20. Morbée S, Vermote B, Waterschoot J, Dieleman L, Soenens B, Van den Bergh O, et al. Adherence to COVID-19 measures: The critical role of autonomous motivation on a short- and long-term basis. Motiv Sci. 2021;7(4):487-96. DOI: 10.1037/mot0000250
21. Li M, Zhu H. Application of intervention of information motivation behavior skill (IMB) model in the cardiac rehabilitation of patients with coronary heart disease. Pak J Med Sci. 2022;38(6):1627-32. DOI: 10.12669/pjms.38.6.5721
22. Lorenzo-Seva U, Ferrando PJ. FACTOR 9.2: A Comprehensive Program for Fitting Exploratory and Semiconfirmatory Factor Analysis and IRT Models. Applied Psychological Measurement. 2013; 37(6):497-8. DOI: 10.1177/0146621613487794
23. Tabachnick B G, Fidell L S, Osterlind S. Using multivariate statistics (4a ed.). Boston, MA: Allyn & Bacon; 2001.
24. Ferrando P, Anguino-Carrasco C. El análisis factorial como técnica de investigación en psicología. Papeles del Psicol. 2010 [acceso: 06/12/2022]; 31(1):18-33. Disponible en: http://www.redalyc.org/articulo.oa?id=77812441003
25. Hair J, Anderson R, Tatham R, Black W. Análisis Multivariante. Prentice Hall; 1999.
26. Kvarnström K, Westerholm A, Airaksinen M, Liira H. Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research. Pharmaceutics. 2021; 13(7):1100. DOI: 10.3390/pharmaceutics13071100
2. Ministerio de Salud. En el Perú, 40 de cada 100 personas mayores de 15 años sufren de obesidad. Diabetes o hipertensión. Lima: MINSA. 2021 [acceso: 26/02/2023]. Disponible en: https://www.gob.pe/institucion/minsa/noticias/508408-en-el-peru-40-de-cada-100-personas-mayores-de-15-anos-sufren-de-obesidad-diabetes-o-hipertension-arterial
3. Fernandez-Lazaro C, García-González J, Adams D, Fernandez-Lazaro D, Mielgo-Ayuso J, Caballero-Garcia A, et al. Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study. BMC Fam. Pract. 2019; 20(132):1-12. DOI: 10.1186/s12875-019-1019-3
4. Organización Mundial de la Salud. Es hora de actuar: informe de la Comisión Independiente de Alto Nivel de la OMS sobre Enfermedades No Transmisibles. Ginebra: OMS. 2018 [acceso: 16/06/2019]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/272712/9789243514161-spa.pdf?ua=1
5. Ortega J, Sánchez D, Rodríguez O, Ortega J. Adherencia terapéutica: un problema de atención médica. Acta Méd. Grupo Ángeles. 2018 [acceso: 08/12/2022]; 16(3):226-32. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1870-72032018000300226&lng=es
6. Vilcamango-Ugaldez E, Gil-Merino S, Valladares-Garrido M. Factores asociados a la adherencia terapéutica en diabéticos atendidos en dos hospitales peruanos. Rev Cuba de Medicina Mil. 2021 [acceso: 05/12/2022]; 50(2):e02101201. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1201
7. Uchmanowicz B, Chudiak A, Uchmanowicz I, Rosinczuk J, Froelicher E. Factors influencing adherence to treatment in older adults with hypertension. Clin Inter Aging. 2018 [acceso: 07/12/2018]; 13:2425-41. Disponible en: https://www.tandfonline.com/doi/full/10.2147/CIA.S182881
8. Nelson LA, Wallston KA, Kripalani S, LeStourgeon LM, Williamson SE, Mayberry LS. Assessing barriers to diabetes medication adherence using the Information-Motivation-Behavioral skills model. Diabetes Res Clin Pract. 2018; 142:374-84. DOI: 10.1016/j.diabres.2018.05.046
9. Padilla V, Morales J. Adherencia al tratamiento en enfermedades crónicas en adultos mayores. Dom. Cien. 2020 [acceso: 20/02/2022]; 6(4):68-80. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8385958
10. Rodríguez-Reyes J, Fonseca-González K, Salazar-Rodríguez J, Marrero-Martínez D. Adherencia terapéutica en hipertensos con incremento matutino de la presión arterial. Rev Cub de Med. 2020 [acceso: 06/12/2022]; 59(3):e1368. Disponible en: https://revmedicina.sld.cu/index.php/med/article/view/1368
11. Al-Sahouri A, Merrell J, Snelgrove S. Barriers to good glycemic control levels and adherence to diabetes management plan in adults with Type-2 diabetes in Jordan: a literature review. Patient Prefer Adherence. 2019; 13:675-93. DOI: 10.2147%2FPPA.S198828
12. Unni E, Bae S. Exploring a New Theoretical Model to Explain the Behavior of Medication Adherence. Pharmacy. 2022; 10(2):43. DOI: 10.3390/pharmacy10020043
13. Zahmatkeshan N, Rakhshan M, Zarshenas L, Kojuri J, Khademian Z. The Effect of Applying the Information-Motivation-Behavioral Skills Model on Treatment Adherence in Patients with Cardiovascular Disease: A Quasi-Experimental Study. Int J Community Based Nurs Midwifery. 2021; 9(3):225-37. DOI: 10.30476%2Fijcbnm.2021.88987.1563
14. Lee M, Park Y. The effectiveness of the information-motivation-behavioral skills model-based intervention on preventive behaviors against respiratory infection among community-dwelling older adults. Patient Educ Couns. 2021;104(8):2028-36. DOI: 10.1016/j.pec.2021.01.016
15. Luo Y, Yao L, Zhou L, Yuan F, Zhong X. Factors influencing health behaviours during the coronavirus disease 2019 outbreak in China: an extended information-motivation-behaviour skills model. Public Health. 2020; 185:298-305. DOI: 10.1016/j.puhe.2020.06.057
16. Bakir E, Çavusoglu H, Mengen E. Effects of the Information-Motivation-Behavioral Skills Model on Metabolic Control of Adolescents with Type 1 Diabetes in Turkey: Randomized Controlled Study. J. Pediatr. Nurs. 2021;58: e19-e27. DOI: 10.1016/j.pedn.2020.11.019
17. Fisher J, Fisher W. Changing AIDS-risk behavior. Psychol Bull. 1992;111(3):455-74. DOI: 10.1037/0033-2909.111.3.455
18. Dubov A, Altice F, Fraenkel L. An information-motivation-behavioral skills model of PrEP uptake. AIDS Behav. 2018;22(11):3603-16. DOI: 10.1007/s10461-018-2095-4
19. Furtado de Souza T, Fátima Colet C, Heineck I. Knowledge and information levels and adherence to oral anticoagulant therapy with warfarin in patients attending primary health care services. J Vasc Bras. 2018;17(2):109-116. DOI: 10.1590/1677-5449.012017
20. Morbée S, Vermote B, Waterschoot J, Dieleman L, Soenens B, Van den Bergh O, et al. Adherence to COVID-19 measures: The critical role of autonomous motivation on a short- and long-term basis. Motiv Sci. 2021;7(4):487-96. DOI: 10.1037/mot0000250
21. Li M, Zhu H. Application of intervention of information motivation behavior skill (IMB) model in the cardiac rehabilitation of patients with coronary heart disease. Pak J Med Sci. 2022;38(6):1627-32. DOI: 10.12669/pjms.38.6.5721
22. Lorenzo-Seva U, Ferrando PJ. FACTOR 9.2: A Comprehensive Program for Fitting Exploratory and Semiconfirmatory Factor Analysis and IRT Models. Applied Psychological Measurement. 2013; 37(6):497-8. DOI: 10.1177/0146621613487794
23. Tabachnick B G, Fidell L S, Osterlind S. Using multivariate statistics (4a ed.). Boston, MA: Allyn & Bacon; 2001.
24. Ferrando P, Anguino-Carrasco C. El análisis factorial como técnica de investigación en psicología. Papeles del Psicol. 2010 [acceso: 06/12/2022]; 31(1):18-33. Disponible en: http://www.redalyc.org/articulo.oa?id=77812441003
25. Hair J, Anderson R, Tatham R, Black W. Análisis Multivariante. Prentice Hall; 1999.
26. Kvarnström K, Westerholm A, Airaksinen M, Liira H. Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research. Pharmaceutics. 2021; 13(7):1100. DOI: 10.3390/pharmaceutics13071100
Published
2023-06-20
How to Cite
1.
Santa-Cruz-Espinoza H, Araujo-Robles ED. Treatment adherence scale for patients with diabetes and arterial hypertension. Rev Cubana Med Milit [Internet]. 2023 Jun. 20 [cited 2025 Apr. 3];52(3):e02302673. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/2673
Issue
Section
Research Article
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.
